Search
for

    Glossary Carbamazepine

    medication used to treat epilepsy and neuropathic pain

    Carbamazepine, also known by the brand name Tegretol, is a medication primarily used to treat epilepsy and neuropathic pain. It works by stabilizing the electrical activity in the brain, which helps to prevent seizures and reduce pain signals. Additionally, it is sometimes prescribed for bipolar disorder to help manage mood swings.

    Sort by

    Research 30 of 263

    1. Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy Acta Neurologica Scandinavica · 1983 · 55 citations
    2. Lupus and Pulmonary Nodules Consistent With Bronchiolitis Obliterans Organizing Pneumonia Induced by Carbamazepine Mayo Clinic proceedings · 1997 · 24 citations
    3. The Influence of Valproic Acid and Carbamazepine Treatment on Serum Biotin and Zinc Levels and on Biotinidase Activity Journal of child neurology · 2011 · 21 citations
    4. Serum Biotinidase Activity in Children Treated With Valproic Acid and Carbamazepine Journal of child neurology · 2009 · 16 citations
    5. Possible Carbamazepine-Induced Reversible Onychomadesis International Journal of Dermatology · 1989 · 13 citations
    6. Carbamazepine-Induced Hair Loss Dicp-The annals of pharmacotherapy · 1985 · 12 citations
    7. Concurrence of Palmoplantar Psoriasiform Eruptions and Hair Loss during Carbamazepine Treatment Acta dermato-venereologica · 2008 · 10 citations
    8. Alopecia with carbamazepine in two patients with focal seizures Journal of neurology, neurosurgery and psychiatry · 1997 · 7 citations
    9. [A case of hair loss induced by carbamazepine]. PubMed · 2004 · 2 citations
    10. [Visual field defect in a patient given sodium valporate then carbamazepine: possible effect of aminotransferase inhibition]. PubMed · 2002 · 1 citations
    11. Identification of drug-specific public TCR driving severe cutaneous adverse reactions Nature communications · 2019 · 88 citations
    12. Hair loss in psychopharmacology. Annals of Clinical Psychiatry · 2000 · 79 citations
    13. The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective International Clinical Psychopharmacology · 2013 · 65 citations
    14. Hair Loss in Psychopharmacology Annals of clinical psychiatry · 2000 · 63 citations
    15. Alopecia and Mood Stabilizer Therapy Annals of Clinical Psychiatry · 1996 · 38 citations
    16. Dermatologic Side Effects of Psychotropic Medications Psychosomatics · 2013 · 31 citations
    17. Psychotropic Medication and Drug-Related Alopecia Psychosomatics · 1991 · 30 citations
    18. DERMATOLOGIC SIDE EFFECTS OF PSYCHOPHARMACOLOGIC AGENTS Dermatologic Clinics · 1996 · 16 citations
    19. Temporal lobe epilepsy exacerbation during pharmacological inhibition of endogenous neurosteroid synthesis BMJ Case Reports · 2013 · 13 citations
    20. Psychoactive drugs and skin Journal of the European Academy of Dermatology and Venereology · 2003 · 12 citations
    21. Safety and tolerability of antiepileptic drugs in women with epilepsy (literature review and own data) Russkij žurnal detskoj nevrologii · 2019 · 6 citations
    22. Obesity, polycystic ovarian syndrome and thyroid dysfunction in women with epilepsy Annals of Indian Academy of Neurology · 2012 · 6 citations
    23. Progressively intractable seizures, focal alopecia, and hemimegalencephaly Neurology · 1994 · 4 citations
    24. Antiseizure Medication-Induced Alopecia: A Literature Review Medicines · 2023 · 3 citations
    25. SAT-214 Satoyoshi Syndrome: A Rare Cause of Premature Ovarian Failure Journal of the Endocrine Society · 2019 · 3 citations
    26. A blistering child: sudden erythema with blisters in a sick girl European Journal of Dermatology · 2022 · 1 citations
    27. SAFETY AND TOLERABILITY OF ANTIEPILEPTIC DRUGS AT WOMEN WITH EPILEPSY (DATA OF SVT. LUKA’S INSTITUTE OF CHILD NEUROLOGY AND EPILEPSY) Russkij žurnal detskoj nevrologii · 2015 · 1 citations
    28. How Should You Use the Lab to Monitor Patients Taking a Mood Stabilizer Current psychiatry · 2014 · 1 citations
    29. Prevalence of Dermatologic Side Effects of Mood Stabilizers in Bipolar Disorder: A Systematic Review and A Meta-Analysis European Psychiatry · 2025
    30. Understanding the formation mechanism of drug-polymer inclusion complex by structure elucidation and theoretical calculation 2023